We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

VINP:NASDAQVinci Compass Investments Ltd. Analysis

Data as of 2026-05-09 - not real-time

$10.90

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

VINP trades around $10.90, well below its DCF‑derived fair value of $55.71, implying roughly a 33% upside potential. Valuation metrics such as a forward P/E of 8.6 and a price‑to‑book of 1.87 reinforce the discount relative to peers, while the company’s dividend yield of 5.7% is attractive but the payout ratio exceeds 100%, raising sustainability concerns. Technical signals are mixed: the 20‑day SMA sits just above price, the MACD histogram is negative and the signal line is bearish, yet the RSI hovers near 49 and the market direction is neutral, with price perched between a support of $10.40 and resistance near $11.68. Volume is on an increasing trend, suggesting growing trader interest ahead of the Q1 2026 earnings release scheduled for May 11. Recent news of a strategic combination with BACS Asset Management in Argentina expands the firm’s geographic footprint and could unlock additional revenue streams. The balance sheet is strong, featuring $1.81 bn in cash against $1.13 bn of debt, and operating cash flow remains robust at $274 m. However, volatility is elevated at 28% over the past 30 days and the max drawdown sits at –26%, indicating notable price swings. The beta near 1 points to market‑aligned risk, while the Brazilian operating environment adds medium‑level regulatory and geographic exposure. Overall, the stock appears dramatically undervalued, but investors must weigh the high dividend payout and short‑term technical weakness against the long‑term valuation case and strategic growth initiatives.
Given the current pricing, strong cash position, and expansion catalyst, a disciplined buying approach is warranted, while monitoring earnings guidance and dividend policy for signs of improved sustainability.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 7/10

Key Factors

  • Upcoming Q1 earnings release may drive volatility
  • Technical indicators show bearish MACD but neutral RSI
  • High dividend yield with unsustainable payout

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Significant valuation gap to DCF fair value
  • Strategic combination with BACS Asset Management expanding revenue base
  • Strong cash generation and low price‑to‑sales multiple

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • Long‑term upside of ~33% versus fair value
  • Asset management sector fundamentals and Brazil market recovery potential
  • Robust balance sheet and growing international footprint

Key Metrics & Analysis

Financial Health

Revenue Growth5.90%
Profit Margin22.26%
P/E Ratio16.8
ROE10.98%
ROA4.13%
Debt/Equity54.87
P/B Ratio1.9
Op. Cash Flow$274.0M
Free Cash Flow$172.5M
Industry P/E16.4

Technical Analysis

TrendNeutral
RSI48.9
Support$10.40
Resistance$11.68
MA 20$11.01
MA 50$10.82
MA 200$11.35
MACDBearish
VolumeIncreasing
Fear & Greed Index90.73

Valuation

Fair Value$55.71
Target Price$14.49
Upside/Downside32.95%
GradeUndervalued
TypeValue
Dividend Yield5.70%

Risk Assessment

Beta0.99
Volatility28.31%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.